AstraZeneca offers $10B to buy drugmaker Rhythm

ASTRAZENECA made an offer of about $10 billion to acquire obesity drugmaker Rhythm Pharmaceuticals, according to three people familiar with the matter.

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.